Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Its the only compound in this comparison with active FDA approval granted in 2010 under the brand name Egrifta for reducing excess visceral abdominal fat in HIV-associated lipodystrophy which sets it apart from AOD-9604 and most other peptides discussed alongside it
The defining mechanism reported for TB-500 in the literature is its interaction with actin , a fundamental protein of the cell cytoskeleton
Roll the vial gently for several minutes
Step 2: Custom Treatment Administration Dr
It carries two defining structural modifications: an N-terminal acetyl group and a bulky lipophilic C-terminal adamantane (diamondoid) group, the motif characteristic of Peptide 021
US$ 23.84
US$ 25.79
US$ 22.69
US$ 25.75
US$ 23.04
US$ 21.39
